Keyphrases
Metabolic Inhibitors
100%
Patient-derived Xenograft
100%
Phenformin
100%
Pancreatic Ductal Adenocarcinoma
50%
Metformin
30%
BPTES
20%
Dichloroacetate
20%
Tumor Inhibition
20%
Aminooxyacetate
20%
Chloroquine
20%
Autophagy Inhibitor
10%
Transaminases
10%
Patient-derived
10%
Library of Integrated Network-based Cellular Signatures
10%
In Vivo Antitumor Activity
10%
Pancreatic Tumor
10%
Response Rate
10%
Pyruvate Dehydrogenase Kinase Inhibitor
10%
Baseline Reduction
10%
Mitochondrial Complex I Inhibitor
10%
Oxidized Glutathione
10%
1,3,4-thiadiazol
10%
Antitumor Efficacy
10%
Tumor Doubling Time
10%
Gene Set Enrichment Analysis
10%
Glutaminase Inhibitor
10%
Aggressive Growth
10%
Low Response
10%
Medicine and Dentistry
Phenformin
100%
Xenograft
100%
Pancreas Cancer
100%
Pancreas Adenocarcinoma
50%
Glycon
30%
Cancer Inhibition
20%
Chloroquine
20%
Dichloroacetic Acid
20%
Aminooxyacetic Acid
20%
Phosphotransferase Inhibitor
10%
Aminotransferase Inhibitor
10%
Drug Megadose
10%
Therapeutic Agent
10%
Reduced Nicotinamide Adenine Dinucleotide Dehydrogenase (Ubiquinone)
10%
Pyruvate Dehydrogenase Kinase
10%
Gene Set Enrichment
10%
Glutathione Disulfide
10%
Pancreas Tumor
10%
Autophagy
10%
Glutaminase
10%
Pharmacology, Toxicology and Pharmaceutical Science
Phenformin
100%
Pancreas Cancer
100%
Pancreas Adenocarcinoma
50%
Metformin
30%
Dichloroacetic Acid
20%
Chloroquine
20%
Aminooxyacetic Acid
20%
Cancer Inhibition
20%
Glutathione Disulfide
10%
Reduced Nicotinamide Adenine Dinucleotide Dehydrogenase (Ubiquinone)
10%
Phosphotransferase Inhibitor
10%
Glutaminase
10%
Pancreas Tumor
10%
Pyruvate Dehydrogenase Kinase
10%
Aminotransferase Inhibitor
10%
Biochemistry, Genetics and Molecular Biology
Growth Inhibition
66%
KRAS
33%
Glutathione
33%
Transaminase
33%
Pyruvate Dehydrogenase Kinase
33%
Autophagy
33%
Gene Set Enrichment Analysis
33%
Glutaminase
33%